Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe history now shows a newer release revision (v3.6.5) replacing the previous revision (v3.6.4). This reflects a standard site/software update rather than a change to the study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe study record history now lists a new revision: v3.6.4, replacing the previous v3.6.3. This indicates a minor system update to the ClinicalTrials.gov record page.SummaryDifference0.1%

- Check51 days agoChange DetectedNew Revision: v3.6.3 appears in the history, replacing the previous v3.6.2 entry. This signifies an update to the study record's metadata.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The older revision v3.6.0 was removed from the visible history.SummaryDifference0.1%

- Check72 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The record history now shows the latest revision as v3.6.0 and removes the earlier v3.5.5 entry from the history.SummaryDifference0.5%

- Check79 days agoChange DetectedA new revision entry v3.5.5 was added to the history, replacing the previous v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.